Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
about
Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitisCalcium Phosphate as a Key Material for Socially Responsible Tissue Engineering.Treatment of Abnormal Vaginal Microbiota before Frozen Embryo Transfer: Case-Report and Minireview to Discuss the Longitudinal Treatment Efficacy of Oral Clindamycin.Nanoparticulate drug delivery platforms for advancing bone infection therapies.Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice.A new dye uptake assay to test the activity of antibiotics against intracellular Francisella tularensis.Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.Polymorphism in Commercial Sources of Fusidic Acid: A Comparative Study of the In Vitro Release Characteristics of Forms I and III from a Marketed Pharmaceutical Cream.Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. II. Antibacterial and osteoblastic response.Potent in vitro synergism of fusidic acid (FA) and berberine chloride (BBR) against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection
P2860
Q28086953-586F4CED-F7AB-4FB2-8A0D-1B093CC8D23AQ30376710-53B84A66-5778-4EE9-9C4A-AE0BBDC5509EQ33809638-DDF7BAEA-EBA8-4ED1-9ECE-06F7B844B219Q35373671-7CC3042B-DD5F-4654-A2EA-27573EF1364AQ36666985-2FD6DDB9-C7C6-4C6E-B2EE-3F0B0BFDA12EQ37642305-A64E0462-90C9-4DC8-B72F-CF91FB929685Q38686596-CD0928F9-78DD-461C-923C-BFEDC09D95E2Q42718244-30DF9F6E-5BAB-4F04-9079-2877B44AB54BQ42829153-AED012A6-A4F6-4C1D-8219-9BFFD0B56BD7Q51063904-D0241169-373A-4FD5-9393-C4A84E10EB41Q58788178-2DB22001-54D2-4EE3-BF3B-7BE885FDA2FC
P2860
Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Activity of fusidic acid again ...... ith linezolid and clindamycin.
@en
Activity of fusidic acid again ...... ith linezolid and clindamycin.
@nl
type
label
Activity of fusidic acid again ...... ith linezolid and clindamycin.
@en
Activity of fusidic acid again ...... ith linezolid and clindamycin.
@nl
prefLabel
Activity of fusidic acid again ...... ith linezolid and clindamycin.
@en
Activity of fusidic acid again ...... ith linezolid and clindamycin.
@nl
P2093
P356
P1476
Activity of fusidic acid again ...... with linezolid and clindamycin
@en
P2093
Denis Pierard
Peter C Appelbaum
Sandrine Lemaire
P304
P356
10.1093/CID/CIR165
P407
P478
52 Suppl 7
P577
2011-06-01T00:00:00Z